Guangxi Zhai
- Pharmaceutical Science top 0.05%
- Biomaterials top 0.2%
- Molecular Biology top 2%
- Molecular Medicine top 0.1%
- Biomedical Engineering top 1%
- Co-authors
- Xiaoye YangYingjie ZhaiChenyu GuoAihua YuFengliang CaoJianbo JiHong‐Xiang LouHongliang Du
- Topics
- Nanoparticle-Based Drug Delivery (63 papers)Nanoplatforms for cancer theranostics (47 papers)Advanced Drug Delivery Systems (40 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Guangxi Zhai
170 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Pharmaceutical Science 3.0k
- Biomaterials 2.8k
- Molecular Biology 2.7k
- Molecular Medicine 1.9k
- Biomedical Engineering 1.8k
Countries citing papers authored by Guangxi Zhai
This map shows the geographic impact of Guangxi Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangxi Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangxi Zhai more than expected).
Fields of papers citing papers by Guangxi Zhai
This network shows the impact of papers produced by Guangxi Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangxi Zhai. The network helps show where Guangxi Zhai may publish in the future.
Co-authorship network of co-authors of Guangxi Zhai
This figure shows the co-authorship network connecting the top 25 collaborators of Guangxi Zhai. A scholar is included among the top collaborators of Guangxi Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangxi Zhai. Guangxi Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 11 | |
| 3 | 7 | |
| 4 | 10 | |
| 5 | 7 | |
| 6 | 19 | |
| 7 | 9 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 14 | |
| 11 | 2 | |
| 12 | 12 | |
| 13 | 25 | |
| 14 | 6 | |
| 15 | 26 | |
| 16 | 62 | |
| 17 | 14 | |
| 18 | 15 | |
| 19 | 12 | |
| 20 | 16 |
About Guangxi Zhai
Guangxi Zhai is a scholar working on Pharmaceutical Science, Molecular Medicine and Biomaterials, having authored 173 papers that have together received 9.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (63 papers), Nanoplatforms for cancer theranostics (47 papers) and Advanced Drug Delivery Systems (40 papers). The work is most often cited by research in Pharmaceutical Science (3.0k citations), Molecular Medicine (1.9k citations) and Biomaterials (2.8k citations). Guangxi Zhai has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoye Yang, Yingjie Zhai, Chenyu Guo, Aihua Yu, Fengliang Cao, Jianbo Ji, Hong‐Xiang Lou, Hongliang Du, Yanwei Xi and Yan Gao. Their work appears in journals such as ACS Nano, Biomaterials and Coordination Chemistry Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.